Cargando…

FRI648 GLP-1RA And SGLT2i Treatments May Show Improved Depression Metrics In Diabetes Treatment

Disclosure: A. Jain: None. L. Esper: None. J. Powell: None. K. Meyer: None. S. Sen: None. Background: Depression is a widespread condition that develops due to a multitude of etiologies. Type 2 Diabetes (T2DM) is associated with several comorbidities, including depression. A class of T2DM medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, Arad, Esper, Layal, Powell, Joseph, Meyer, Kristin, Sen, Sabyasachi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554689/ http://dx.doi.org/10.1210/jendso/bvad114.867

Ejemplares similares

FRI605 Inhibition Of Intestinal SGLT1 With Mizagliflozin For The Treatment Of Post-bariatric Hypoglycemia
por: Margaret Lawler, Helen, et al.
Publicado: (2023)

FRI657 Case Series On GLP-1 Receptor Agonist Related Acute Pancreatitis
por: Kumar Kulkarni, Abhigna Uday, et al.
Publicado: (2023)

LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
por: Hoog, Meredith, et al.
Publicado: (2022)

FRI652 Type 2 Diabetes Management: More GLP1 Agonists And Less Metformin?
por: Lopez Maldonado, Francisco J, et al.
Publicado: (2023)

FRI639 Effect Of Early Initiation Of GLP-1 RAs On Weight Reduction Among People With Type 2 Diabetes
por: Chinthammit, Chanadda, et al.
Publicado: (2023)

ODP171 Choosing GLP-1RA Over Insulin for Patients with Type 2 Diabetes and Severe Hyperglycemia
por: Mamtani, Raashi, et al.
Publicado: (2022)

PSUN172 Prescribing SGLT-2 Inhibitors and GLP-1 Agonists in Primary Care: Improving Rates of Guideline-Concordant Practice
por: Schuetz, Samantha, et al.
Publicado: (2022)

FRI607 SGLT2 Inhibition Improves Muscle Oxidative Capacity And Its Relationship With Cardiac Performance In Patients With T2D And Heart Failure
por: Qin, Yuejuan, et al.
Publicado: (2023)

THU275 Tacrolimus Levels And Kidney Function In Kidney Transplanted (KT) Patients With Diabetes On Glucagon Like-1 Receptor Agonists (GLP1-RA)
por: Campana, Mario S, et al.
Publicado: (2023)

FRI612 Tirzepatide For The Treatment Of Post-bariatric Surgery Hypoglycemia And Early Dumping Syndrome
por: Frederick Stortz, Ethan, et al.
Publicado: (2023)

MON-648 Chronic Unpredictable Environmental Stress May Induce Predisposition to Diabetes Mellitus
por: Raghav, Alok
Publicado: (2020)

Mesenteric Ischemia in a Young Man With the First Presentation of Diabetic Ketoacidosis
por: Esper, Layal
Publicado: (2021)

FRI637 Missed MODY With Complex Mutation
por: Bulchandani, Sheetal, et al.
Publicado: (2023)

FRI603 Treatment Of Severe Refractory Hypoglycemia Due To Malignant Insulinoma With A Novel Anti-insulin Receptor Antibody
por: Osataphan, Soravis, et al.
Publicado: (2023)

FRI604 Stem-cell Derived Islets For Treating Diabetes
por: Rust, William L, et al.
Publicado: (2023)

FRI617 Targeting Unc119b For Insulin Sensitization
por: Mittal, Ayushi, et al.
Publicado: (2023)

FRI618 Lifetime Risk Of Nontraumatic Lower-extremity Amputation
por: Ding, Ning, et al.
Publicado: (2023)

FRI664 The Impact Of Prediabetes Diagnosis On The Prevalence Of Postbariatric Hypoglycemia
por: Reshma Shariff, Julia Rose, et al.
Publicado: (2023)

FRI613 Sex Differences In Human Islet Transcriptional Responses To Inflammation
por: Webster, Kierstin L, et al.
Publicado: (2023)

FRI636 Sleep Architecture In Diabetic Patients With Sleep Apnea On Metformin
por: Varma, Madhu, et al.
Publicado: (2023)

FRI631 Insulin Antibody Mediated Extremely Insulin Resistant In Pregnancy
por: Liu, Zhao, et al.
Publicado: (2023)

FRI668 Insulinoma As A Cause Of New Onset Hypoglycemic Episodes
por: Zahra, Sundas, et al.
Publicado: (2023)

FRI666 Postbariatric Hypoglycemia: The Brody School Of Medicine Institutional Experience
por: Jiang, Zhaozhi, et al.
Publicado: (2023)

FRI628 Subnormal Fructosamine Levels In Non Diabetic Pregnant Women
por: Kabadi, Udaya M, et al.
Publicado: (2023)

THU387 Euglycemic Diabetic Ketoacidosis And SGLT-2 Inhibitor Use
por: Abrahimi, Nora, et al.
Publicado: (2023)

THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023)

MON-130 Optimal Glycemic Control in a Patient with HNF1A MODY with GLP1-RA Monotherapy: Implications for Future Therapy
por: Fantasia, Kathryn, et al.
Publicado: (2019)

FRI646 Dulaglutide-induced Acute Liver Injury - A Case Report
por: Shahid, Maham, et al.
Publicado: (2023)

FRI658 Diabetic Ketoacidosis Masked By Cannabis In Type 2 Diabetes Mellitus
por: Bosques-Lorenzo, Jaymilitte, et al.
Publicado: (2023)

FRI640 Adherence To Diabetic Retinopathy Screening Guidelines In An Adolescent Patient Population
por: Sami, Asra, et al.
Publicado: (2023)

FRI662 Quetiapine Induced Severe Hypoglycemia In Elderly Patients Without Diabetes
por: gusov, timur, et al.
Publicado: (2023)

ODP242 Safety of SGLT2-Inhibitors in Patients with Multiple Myeloma and Diabetes
por: Shyu, Margaret, et al.
Publicado: (2022)

ODP244 SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges
por: Penna, Laurianne El Musa, et al.
Publicado: (2022)

THU264 Enteric Activity Enhanced Ileal GLP-1 Secretion
por: Chen, Yixin, et al.
Publicado: (2023)

SAT-662 Effects of SGLT Inhibitors or GLP1 Analogues on Glucose Homeostasis and Body Weight in Patients with Type 1 Diabetes: A Network Meta-Analysis
por: Lim, Soo, et al.
Publicado: (2020)

FRI643 Tirzepatide Associated Partial Small Bowel Obstruction: A Case Report
por: Mathew, Anoopa, et al.
Publicado: (2023)

FRI645 A Case Of Diabetic Ketoacidosis After Initiation Of Decitabine And Venetoclax Chemotherapy
por: Maini, Rohan, et al.
Publicado: (2023)

FRI629 A Mysterious Case Of Mother's Battle With Diabetic Ketoacidosis During Pregnancy
por: Sittirat, Petchpailin D, et al.
Publicado: (2023)

FRI647 Hemiballismus - A Rare Presentation Of Uncontrolled Diabetes Mellitus Type 2
por: Lontoc Macrohon, Calvin, et al.
Publicado: (2023)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_viststqhlvda3mv9ee43lp8e0h